Article Details

Fusion Pharmaceuticals doses first subject in prostate cancer trial

Retrieved on: 2024-05-10 23:17:30

Tags for this article:

Click the tags to see associated articles and topics

Fusion Pharmaceuticals doses first subject in prostate cancer trial. View article details on hiswai:

Excerpt

The gold standard of business intelligence. Find out more. Related Company Profiles. Fusion Pharmaceuticals Inc · View all. The Phase II dose ...

Article found on: www.clinicaltrialsarena.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo